These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2412973)

  • 1. Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from Klebsiella pneumoniae.
    Rudent A; Zalisz R; Quero AM; Smets P
    Int J Immunopharmacol; 1985; 7(4):525-31. PubMed ID: 2412973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.
    Robert D; Quillon JP; Ivanoff B; Beaudry Y; Fontanges R; Normier G; Pinel AM; D'hinterland LD
    Infect Immun; 1979 Nov; 26(2):515-9. PubMed ID: 94908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of RU 41740 aerosol treatment on mouse bronchoalveolar cells, and protection afforded against influenza virus infection.
    Michel F; Rudent A; Labarre C; Quero AM; Zalisz R; Smets P
    Int J Immunopharmacol; 1987; 9(7):775-81. PubMed ID: 2828252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klebsiella pneumoniae alleviates influenza-induced acute lung injury via limiting NK cell expansion.
    Wang J; Li F; Sun R; Gao X; Wei H; Tian Z
    J Immunol; 2014 Aug; 193(3):1133-41. PubMed ID: 24951819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection.
    Johansson BE; Kilbourne ED
    J Virol Methods; 1991 Nov; 35(1):109-14. PubMed ID: 1666111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered live attenuated Salmonella Typhimurium protects mice against lethal infection with H1N1 influenza virus.
    Kamble NM; Hajam IA; Lee JH
    Vet Microbiol; 2017 Mar; 201():1-6. PubMed ID: 28284594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
    Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
    Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity.
    Arulanandam BP; O'Toole M; Metzger DW
    J Infect Dis; 1999 Oct; 180(4):940-9. PubMed ID: 10479116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan.
    Irinoda K; Masihi KN; Chihara G; Kaneko Y; Katori T
    Int J Immunopharmacol; 1992 Aug; 14(6):971-7. PubMed ID: 1428370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guérin.
    Spencer JC; Ganguly R; Waldman RH
    J Infect Dis; 1977 Aug; 136(2):171-5. PubMed ID: 894076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
    Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
    Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.